Boundless Bio (NASDAQ: BOLD) major Tang Capital holder adds 4,863 shares
Rhea-AI Filing Summary
Boundless Bio, Inc. reported that investment entities managed by Tang Capital Management, associated with ten percent owner Kevin Tang, purchased a total of 4,863 shares of common stock in open market or private transactions at $2.44 per share between July 17 and July 21, 2026, through indirect ownership.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 4,863 shares
Net Buy
3 txns
Insider
TANG KEVIN, TANG CAPITAL MANAGEMENT LLC
Role
10% Owner | 10% Owner
Bought
4,863 shs ($12K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock F1, F2 | 2,975 | $2.44 | $7K |
| Purchase | Common Stock F1, F2 | 1,623 | $2.44 | $4K |
| Purchase | Common Stock F1, F2 | 265 | $2.44 | $646.60 |
Holdings After Transaction:
Common Stock — 2,858,935 shares (Indirect, See Footnote)
Footnotes (2)
- F1. The prices reported are weighted-average prices. These shares were all purchased at $2.44. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the SEC staff, upon request, all information regarding the number of shares purchased at each price within the ranges set forth in Footnote 1.
- F2. Tang Capital Partners, LP ("TCP") beneficially owns 655,170 shares, Tang Capital Partners International, LP ("TCPI") beneficially owns 893,434 shares, Tang Capital Partners III, Inc. ("TCP III") beneficially owns 655,161 shares, and Tang Capital Partners IV, Inc. ("TCP IV") beneficially owns 655,170 shares. Kevin Tang is the sole manager of Tang Capital Management, LLC, which is the general partner of TCP and TCPI. Kevin Tang is the sole director and Chief Executive Officer of TCP III and TCP IV, which are indirectly wholly owned by TCP. Mr. Tang has a pecuniary interest in the shares beneficially held by TCP, TCPI, TCP III and TCP IV.
Key Figures
Total shares purchased: 4,863 shares
Purchase price: $2.44 per share
July 21, 2026 purchase: 2,975 shares
+5 more
8 metrics
Total shares purchased
4,863 shares
Common stock bought between July 17 and July 21, 2026
Purchase price
$2.44 per share
Weighted-average price for reported purchases
July 21, 2026 purchase
2,975 shares
Common stock bought indirectly at $2.44 per share
July 20, 2026 purchase
1,623 shares
Common stock bought indirectly at $2.44 per share
July 17, 2026 purchase
265 shares
Common stock bought indirectly at $2.44 per share
Tang Capital Partners, LP holdings
655,170 shares
Beneficially owned by Tang Capital Partners, LP
Tang Capital Partners International, LP holdings
893,434 shares
Beneficially owned by Tang Capital Partners International, LP
Tang Capital Partners III & IV holdings
655,161 and 655,170 shares
Beneficially owned by Tang Capital Partners III, Inc. and IV, Inc.
Key Terms
weighted-average prices, beneficially owns, pecuniary interest, indirectly wholly owned
4 terms
weighted-average prices financial
"The prices reported are weighted-average prices."
beneficially owns financial
"Tang Capital Partners, LP ("TCP") beneficially owns 655,170 shares"
Beneficially owns means a person or entity enjoys the economic benefits and control of a security even if the legal title or registration is held in another name. Think of it like having the keys and profits from a car that is registered to a friend: you use it, benefit from it, and make decisions about it even though the official paperwork lists someone else. For investors, this matters because it reveals who truly controls shares, affects voting power, potential conflicts of interest, and regulatory disclosure obligations.
pecuniary interest financial
"Mr. Tang has a pecuniary interest in the shares beneficially held"
indirectly wholly owned financial
"TCP III and TCP IV, which are indirectly wholly owned by TCP"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider buying did Tang Capital report in Boundless Bio (BOLD)?
Tang Capital–managed entities reported buying 4,863 shares of Boundless Bio common stock. These indirect purchases occurred over three days in July 2026 and are tied to funds in which ten percent owner Kevin Tang has a pecuniary interest.
Were the recent Boundless Bio (BOLD) purchases made under a Rule 10b5-1 trading plan?
The transactions are not affirmed as executed under a Rule 10b5-1 trading plan. The Rule 10b5-1 plan affirmation box is not marked, so these purchases are not reported as being made pursuant to such a pre-arranged plan.